Pharmaceutical Manufacturing Market Trend, Share, Growth, Trends, Size Analysis and Forecast 2028

Pharmaceutical Manufacturing Market

Pharmaceutical Manufacturing Market - By Drug Type (Biologics & Biosimilars and Small Medicines), By Drug Development (In-house and Outsourced), By Formulation (Tablets, Injectables, Capsules, Sprays, Suspensions, and Powders), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Category: Pharmaceutical Report Format : PDF Pages: 120 Report Code: ZMR-6521 Published Date: Jul-2021 Status : Published
Market Size in 2020 Market Forecast in 2028 CAGR (in %) Base Year
USD 401.32 Billion USD 832.11 Billion 11.32% 2020

Pharmaceutical Manufacturing Market

Global Pharmaceutical Manufacturing Industry Prospective:

The global Pharmaceutical Manufacturing market size accrued earnings worth approximately 401.32 ( USD Billion) in 2020 and is predicted to gain revenue of about 832.11 ( USD Billion) by 2028, is set to record a CAGR of nearly 11.32% over the period from 2021 to 2028.

The report offers an assessment and analysis of the Pharmaceutical Manufacturing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Pharmaceutical Manufacturing Market: Overview

Pharmaceutical manufacturing is the method of industrial-scale synthesizing of pharma drugs and it is also a part & parcel of the pharma sector. The procedure of drug production also termed pharmaceutical manufacturing is divided into a number of unit functions including milling, coating, granulation, and tablet pressing. Furthermore, the pharma sector has undergone a humongous change with the evolution of novel & cost-efficient techniques along with the introduction of new approaches in the pharma manufacturing industry. The surge in the funding of pharma manufacturing processes in the pharmaceutical industry will translate into the enlarged scope of the pharmaceutical manufacturing industry in the upcoming years. Apart from this, pharma production downtime & output of product wastage are minimized with the execution of AI & robotic systems.

Global Pharmaceutical Manufacturing MarketRequest Free Sample

Pharmaceutical Manufacturing Market: Growth Drivers

Growing demand for paperless and smart functions in drug production will drive pharmaceutical manufacturing market trends. In addition to this, consistent growth in the domain of personalized medicine has led to the exploration & development of patient-centric models, thereby further creating new growth avenues for the pharmaceutical manufacturing business. Apparently, altering the landscape of small drugs in drug potency terms, medicine complexity, business makeup, and production trends is predicted to aid demand for small drugs in the pharma sector. This, in turn, will prompt the expansion of the pharmaceutical manufacturing industry over the forecast period.

Moreover, an increase in medicine approvals by regulatory authorities such as the U.S. FDA is projected to boost drug manufacturing procedures, thereby completely transforming the phase of growth of the pharmaceutical manufacturing industry. Additionally, a massive rise in funding of clinical experiments by pharma firms & surge in research activities on new drug development will steer the growth of the pharmaceutical manufacturing market.

Pharmaceutical Manufacturing Market: Report Scope

Report Attributes Report Details
Report Name Pharmaceutical Manufacturing Market Research Report
Market Size in 2020 USD 401.32 Billion
Market Forecast in 2028 USD 832.11 Billion
Growth Rate CAGR of 11.32%
Number of Pages 255
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Novartis AG, Pfizer, Inc., AstraZeneca, Merck & Co., Inc., Sanofi SA, Johnson & Johnson, Roche Holding AG, AbbVie, Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Cipla Limited, Novo Nordisk A/S, Takeda Pharmaceuticals, Inc., Gilead Sciences, Inc., and Bristol Myers Squibb Company.
Segments Covered By Drug Type, By Drug Development, By Formulation, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Base Year 2020
Historical Year 2018 to 2020
Forecast Year 2021 - 2028
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Pharmaceutical Manufacturing Market: Regional Landscape

North America To Contribute Majorly Towards Global Market Size By 2028

The expansion of the pharmaceutical manufacturing industry in North America during 2021-2028 is due to a huge number of strategic alliances between pharmaceutical firms in countries such as Canada and the U.S. In addition to this, a rise in spending on prescribed medicines in the U.S. will spur regional market size within the next couple of years. Apart from this, an increase in the number of research projects associated with drug efficiency testing activities in Canada and the U.S. will expedite regional market value in the ensuing years.

Pharmaceutical Manufacturing Market: Competitive Landscape

Key players profiled in the report and leveraging the industry landscape are

  • Novartis AG
  • Pfizer, Inc.
  • AstraZeneca
  • Merck & Co., Inc.
  • Sanofi SA
  • Johnson & Johnson
  • Roche Holding AG
  • AbbVie, Inc., Eli Lilly and Company
  • Sun Pharmaceutical Industries Limited
  • Cipla Limited
  • Novo Nordisk A/S
  • Takeda Pharmaceuticals, Inc.
  • Gilead Sciences, Inc.
  • Bristol Myers Squibb Company.

The global Pharmaceutical Manufacturing Market is segmented as follows:

By Drug Type

By Drug Development

  • In-house  
  • Outsourced

By Formulation

  • Tablets
  • Injectables
  • Capsules
  • Sprays
  • Suspensions
  • Powders

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Growing demand for paperless and smart functions in drug production will drive pharmaceutical manufacturing market trends. In addition to this, consistent growth in domain of personalized medicine has led to exploration & development of patient-centric models, thereby further creating new growth avenues for pharmaceutical manufacturing business. 

 

According to Zion market research report, the global Pharmaceutical Manufacturing market Size accrued earnings worth approximately 401.32(USD Billion) in 2020 and is predicted to gain revenue of about 832.11 (USD Billion) by 2028, is set to record a CAGR of nearly 11.32% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is subject to huge number of strategic alliances between pharmaceutical firms in countries such as Canada and the U.S. In addition to this, rise in spending on prescribed medicines in the U.S. will spur regional market size within next couple of years. Apart from this, increase in number of research projects associated with drug efficiency testing activities in Canada and the U.S. will expedite regional market value in ensuing years.   

The key market participants include Novartis AG, Pfizer, Inc., AstraZeneca, Merck & Co., Inc., Sanofi SA, Johnson & Johnson, Roche Holding AG, AbbVie, Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Cipla Limited, Novo Nordisk A/S, Takeda Pharmaceuticals, Inc., Gilead Sciences, Inc.,  and Bristol Myers Squibb Company.

 

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed